Level Four Advisory Services’s 10x Genomics TXG Stock Holding History

Level Four Advisory Services’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$767K	Sell	36,147 -11,503	-24%	-$230K	0.03%	477
2025 Q4	$777K	Sell	47,650 -7,101	-13%	-$107K	0.03%	462
2025 Q3	$640K	Buy	+54,751	New	+$714K	0.02%	498

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Level Four Advisory Services's TXG Position: Q1 2026 in Review

Level Four Advisory Services reduced its 10x Genomics (TXG) stake by 24% in Q1 2026, selling an estimated $230K and leaving 36,147 shares worth $767K. The position accounts for 0.03% of the portfolio, ranked #477.

Level Four Advisory Services first reported a position in TXG in Q3 2025 and has held it in 3 quarters since. The position peaked at $777K in Q4 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Level Four Advisory Services held 36,147 shares of 10x Genomics worth $767K as of Q1 2026.
Level Four Advisory Services sold 11,503 10x Genomics shares in Q1 2026, an estimated $230K.
10x Genomics made up 0.03% of Level Four Advisory Services's portfolio in Q1 2026, its #477 holding.
Level Four Advisory Services first reported a position in 10x Genomics in Q3 2025 and has held it in 3 quarters since.
Level Four Advisory Services's 10x Genomics position peaked at $777K in Q4 2025.
329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Level Four Advisory Services's 13F filing for Q1 2026, filed 14 May 2026.